Found: 182
Select item for more details and to access through your institution.
Using Stable Isotopes and a Bayesian Mixing Model (FRUITS) to Investigate Diet at the Early Neolithic Site of Carding Mill Bay, Scotland.
- Published in:
- Radiocarbon, 2017, v. 59, p. 1275, doi. 10.1017/RDC.2017.39
- By:
- Publication type:
- Article
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1063144
- By:
- Publication type:
- Article
Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 975, doi. 10.3390/cancers15030975
- By:
- Publication type:
- Article
The recent contribution of scientific techniques to the study of Nokalakevi in Samegrelo, Georgia.
- Published in:
- Anatolian Studies (Cambridge University Press), 2021, v. 71, p. 29, doi. 10.1017/S006615462100003X
- By:
- Publication type:
- Article
Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 3, p. e171, doi. 10.1016/j.clml.2022.12.003
- By:
- Publication type:
- Article
Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e279, doi. 10.1016/j.clml.2021.10.008
- By:
- Publication type:
- Article
P-171: Multistate models provide complementary insights into outcomes for patients treated in the UK NCRI Myeloma XI randomised trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S129, doi. 10.1016/S2152-2650(21)02298-9
- By:
- Publication type:
- Article
OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S10, doi. 10.1016/S2152-2650(21)02089-9
- By:
- Publication type:
- Article
OAB-013: Iberdomide (IBER) in combination with dexamethasone (DEX) and daratumumab (DARA), bortezomib (BORT), or carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S9, doi. 10.1016/S2152-2650(21)02087-5
- By:
- Publication type:
- Article
OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S8, doi. 10.1016/S2152-2650(21)02086-3
- By:
- Publication type:
- Article
Sex Differences in Multiple Myeloma Biology but not Clinical Outcomes: Results from 3894 Patients in the Myeloma XI Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 10, p. 667, doi. 10.1016/j.clml.2021.04.013
- By:
- Publication type:
- Article
Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e288, doi. 10.1016/j.clml.2019.09.475
- By:
- Publication type:
- Article
Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e45, doi. 10.1016/j.clml.2019.09.069
- By:
- Publication type:
- Article
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e4, doi. 10.1016/j.clml.2019.09.006
- By:
- Publication type:
- Article
Quadruplet KCRD (Carfilzomib, Cyclophosphamide, Lenalidomide and Dexamethasone) Induction for Newly Diagnosed Myeloma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.003
- By:
- Publication type:
- Article
Characteristics, Treatment Patterns, and Survival Outcomes of Patients with Relapsed/Refractory Multiple Myeloma (RRMM) in North America (NA) and Europe: Findings from the PREAMBLE Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S252, doi. 10.1016/j.clml.2018.07.153
- By:
- Publication type:
- Article
A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S247, doi. 10.1016/j.clml.2018.07.146
- By:
- Publication type:
- Article
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Impact of Thalidomide, Zoledronate and High-dose Therapy with Autologous Stem Cell Support on Patient Reported Outcomes in Multiple Myeloma: Results of the Quality of Life Substudy of the MRC Myeloma IX Randomised Controlled Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e121, doi. 10.1016/j.clml.2017.03.220
- By:
- Publication type:
- Article
Neutral Tumor Evolution in Myeloma is Associated With Poor Response to Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e10, doi. 10.1016/j.clml.2017.03.017
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM Based on Prior Lines and Treatment Exposure: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e116, doi. 10.1016/j.clml.2017.03.211
- By:
- Publication type:
- Article
The Impact of Maintenance Lenalidomide and Depth of Response on the Mutational Status of the Myeloma Clone from Presentation to Relapse.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e100, doi. 10.1016/j.clml.2017.03.181
- By:
- Publication type:
- Article
Lenalidomide and Low-dose Dexamethasone for Treatment of Relapsed/Refractory Multiple Myeloma: Real-world Treatment Patterns from the PREAMBLE Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e126, doi. 10.1016/j.clml.2017.03.229
- By:
- Publication type:
- Article
Integrating Molecular Genetic and Gene Expression Profiling Allows Stratification of Ultra-High Risk Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e1, doi. 10.1016/j.clml.2017.03.003
- By:
- Publication type:
- Article
Depth of Response and MRD with Daratumumab Plus Lenalidomide and Dexamethasone (DRd) vs Lenalidomide and Dexamethasone (Rd) in RRMM: POLLUX.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e17, doi. 10.1016/j.clml.2017.03.029
- By:
- Publication type:
- Article
Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e79, doi. 10.1016/j.clml.2017.03.144
- By:
- Publication type:
- Article
The Role of Adhesion Molecules in Multiple Myeloma.
- Published in:
- Acta Haematologica, 1997, v. 97, n. 1/2, p. 81, doi. 10.1159/000203663
- By:
- Publication type:
- Article
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00795-w
- By:
- Publication type:
- Article
Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00795-w
- By:
- Publication type:
- Article
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-022-00779-2
- By:
- Publication type:
- Article
Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00626-4
- By:
- Publication type:
- Article
Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 2, p. 1, doi. 10.1038/s41408-021-00432-4
- By:
- Publication type:
- Article
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
- By:
- Publication type:
- Article
Mesolithic and Early Neolithic activity along the Dee: excavations at Garthdee Road, Aberdeen.
- Published in:
- Proceedings of the Society of Antiquaries of Scotland, 2014, n. 144, p. 1
- By:
- Publication type:
- Article
New light on oblong forts: excavations at Dunnideer, Aberdeenshire.
- Published in:
- Proceedings of the Society of Antiquaries of Scotland, 2010, n. 140, p. 79
- By:
- Publication type:
- Article
What's cooking? New radiocarbon dates from the earliest phases of the Perth High Street excavations and the question of Perth's early medieval origin.
- Published in:
- Proceedings of the Society of Antiquaries of Scotland, 2005, n. 135, p. 273
- By:
- Publication type:
- Article
When and Why? The Chronology and Context of Flint Mining at Grime's Graves, Norfolk, England.
- Published in:
- Proceedings of the Prehistoric Society, 2018, v. 84, p. 277, doi. 10.1017/ppr.2018.14
- By:
- Publication type:
- Article
Making and Breaking Microliths: A Middle Mesolithic Site at Asfordby, Leicestershire.
- Published in:
- Proceedings of the Prehistoric Society, 2017, v. 83, p. 43, doi. 10.1017/ppr.2017.7
- By:
- Publication type:
- Article
On the Curious Date of the Rylstone Log-Coffin Burial.
- Published in:
- Proceedings of the Prehistoric Society, 2016, v. 82, p. 383, doi. 10.1017/ppr.2016.5
- By:
- Publication type:
- Article
A Second Timber Circle, Trackways, and Coppicing at Holme-next-the-Sea Beach, Norfolk: use of Salt- and Freshwater Marshes in the Bronze Age.
- Published in:
- Proceedings of the Prehistoric Society, 2016, v. 82, p. 227, doi. 10.1017/ppr.2016.3
- By:
- Publication type:
- Article
The Catholme Ceremonial Complex, Staffordshire, UK.
- Published in:
- Proceedings of the Prehistoric Society, 2010, v. 76, p. 135, doi. 10.1017/S0079497X00000487
- By:
- Publication type:
- Article
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 199, doi. 10.1111/ejh.12903
- By:
- Publication type:
- Article
A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2008, v. 81, n. 4, p. 247, doi. 10.1111/j.1600-0609.2008.01121.x
- By:
- Publication type:
- Article
Problematic but promising ponds? Palaeoenvironmental evidence from the Norse Eastern Settlement of Greenland.
- Published in:
- Journal of Quaternary Science, 2011, v. 26, n. 8, p. 854, doi. 10.1002/jqs.1518
- By:
- Publication type:
- Article
Summary findings of the fourth international radiocarbon intercomparison (FIRI)(1998-2001).
- Published in:
- Journal of Quaternary Science, 2002, v. 17, n. 7, p. 633, doi. 10.1002/jqs.702
- By:
- Publication type:
- Article
Long-distance marker horizons from small-scale eruptions: British tephra deposits from the AD 1510 eruption of Hekla, Iceland.
- Published in:
- Journal of Quaternary Science, 1996, v. 11, n. 6, p. 511, doi. 10.1002/(SICI)1099-1417(199611/12)11:6<511::AID-JQS284>3.0.CO;2-C
- By:
- Publication type:
- Article
The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Radon water to air transfer measured in a bathroom in an energy-efficient home with a private well.
- Published in:
- Radiation Protection Dosimetry, 2014, v. 160, n. 1-3, p. 231, doi. 10.1093/rpd/ncu085
- By:
- Publication type:
- Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551
- By:
- Publication type:
- Article